DJIA 17,086.63 -26.91 -0.16%
NASDAQ 4,473.70 17.68 0.40%
S&P 500 1,987.01 3.48 0.18%
market minute promo

Endocyte, Inc. (NASDAQ: ECYT)

6.24 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ECYT $6.24 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.29
Previous Close $6.24
Daily Range $6.16 - $6.44
52-Week Range $6.01 - $33.70
Market Cap $259.0M
P/E Ratio -13.00
Dividend (Yield) $0.00 (0.0%)
Volume 681,482
Average Daily Volume 1,269,610
Current FY EPS -$0.34

Sector

Healthcare

Industry

Drugs

Endocyte, Inc. (ECYT) Description

Endocyte Inc is a biopharmaceutical Company developing targeted therapies for the treatment of cancer and inflammatory diseases. It uses its proprietary technology to create novel small molecule drug conjugates or SMDCs and companion imaging diagnose. Website: http://www.endocyte.com/

News & Commentary Rss Feed

Why Endocyte, Inc. Shares Briefly Popped

Endocyte shares jump after the company reports better-than-expected fourth-quarter results, but here's what investors should really have their eyes on.

Tetraphase Pharmaceuticals (TTPH) Crumbles: Stock Tanks by 16.4% - Tale of the Tape

Will Endocyte (ECYT) Crush Estimates at Its Next Earnings Report? - Tale of the Tape

Will Endocyte (ECYT) Crush Estimates at Its Next Earnings Report? - Tale of the Tape

Isis - Addressing Some Of The Bull Arguments To My Short Thesis

Endocyte Spiked Sharply On Rumored Resumption Of Cancer Drug Trial

Surging Earnings Estimates Signal Good News for Endocyte (ECYT) - Tale of the Tape

Endocyte (ECYT) in Focus: Stock Tanks 14% - Tale of the Tape

Merck Backs Out of Endocyte Vintafolide Deal - Analyst Blog

Morning Market Losers

Endocyte (ECYT) Moving On Heavy Pre-Market Trading

Benzinga's Top #PreMarket Losers

See More ECYT News...

ECYT's Top Competitors

ECYT $6.24 (0.00%)
Current stock: ECYT
JNJ $102.19 (-0.27%)
Current stock: JNJ
NVS $89.02 (-0.27%)
Current stock: NVS
RHHBY $36.82 (-0.03%)
Current stock: RHHBY